检索
AI 对话
analysis
趋势分析
编组
开放平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

Response to brentuximab vedotin in advanced stage MF/Sezary syndrome with low CD-30 expression: "real-life" data of the German Cutaneous Lymphoma Network

Christoph Blazejak,Rene Stranzenbach,Claus-Detlev Klemke,Ann-Kathrin Frenzel,Christina Mitteldorf,Jan P. Nicolay,Marion Wobser,Philipp Schrufer,Rudolf Stadler,Janika Gosmann,Ulrike Wehkamp,Sarja Stendel,Nina Booken,Alexander Kreuter,Edgar Dippel,Maria Weyermann,Chalid Assaf

EUROPEAN JOURNAL OF CANCER（2021）

引用 0|浏览5
暂无评分
关键词
Brentuximab, advanced CTCL, CD30, therapy, mycosis fungoides, Sezary syndrome, real-life data, German Cutaneous Lymphoma Network
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要